Bansisons Tea Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Quarterly Results June 30, 2026

NOVYRA PHARMACHEM LIMITED CIN NO. :- L21001GJ1987PLC171085 | 11t August, 2026 BSE Limited Ground Floor, P.J. Tower Dalal Street Mumbai- 400001 Scrip Code: 519353 Sub: Intimation of Board . Regulation 29 of SEBI (Listi Obligations and Disclosure Requirements) Regulations, 2015, Dear Sir/Madam, Pursuant to Regulation 29 read with other applicable Regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 14th August, 2026 at the Registered Office of the Company inter alia to consider and approve the following: - 1. Unaudited financial result for the quarter ended on 30t June, 2026 along with the Auditor's Limited Review Report. 2. Any other business with the permission of Chairman. Please take the same on your record and oblige. Thanking You. Yours Faithfully, For, Novyra Pharmachem Limited ( formerly known as Bansisons Tea Industries Ltd ) For, Novyra Pharmachem Limited it o, Felify Director/Autho. Signatory Anilkumar Mohanbhai Amreliya Director DIN : 11339148 RS No. 432, T P Scheme No. 3, F P No. 89/A, City Survey No. 3763, Plot No. C, Palky Plot No. A, Ground Floor, Back Side, Pavthawala Compound, B/h Zenith Mill, Vasta Devdi Road, Surat- 395004, Gujarat, India